296 related articles for article (PubMed ID: 25794587)
1. [Value of perineal HistoScanning™ template-guided prostate biopsy].
Hamann MF; Hamann C; Olzem D; Trettel A; Juenemann KP; Naumann CM
Urologe A; 2015 Nov; 54(11):1596, 1598-601. PubMed ID: 25794587
[TBL] [Abstract][Full Text] [Related]
2. Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?
Hamann MF; Hamann C; Trettel A; Jünemann KP; Naumann CM
BMC Urol; 2015 Jul; 15():76. PubMed ID: 26223353
[TBL] [Abstract][Full Text] [Related]
3. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
[TBL] [Abstract][Full Text] [Related]
4. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
[TBL] [Abstract][Full Text] [Related]
5. Computer-aided (HistoScanning) biopsies versus conventional transrectal ultrasound-guided prostate biopsies: do targeted biopsy schemes improve the cancer detection rate?
Hamann MF; Hamann C; Schenk E; Al-Najar A; Naumann CM; Jünemann KP
Urology; 2013 Feb; 81(2):370-5. PubMed ID: 23374806
[TBL] [Abstract][Full Text] [Related]
6. [Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer].
Loch T
Urologe A; 2004 Nov; 43(11):1377-84. PubMed ID: 15517143
[TBL] [Abstract][Full Text] [Related]
7. Detecting Prostate Cancer.
Brock M; von Bodman C; Palisaar J; Becker W; Martin-Seidel P; Noldus J
Dtsch Arztebl Int; 2015 Sep; 112(37):605-11. PubMed ID: 26396046
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
9. Transperineal template-guided biopsy for diagnosis of prostate cancer in patients with at least two prior negative biopsies.
Klatte T; Swietek N; Schatzl G; Waldert M
Wien Klin Wochenschr; 2013 Nov; 125(21-22):669-73. PubMed ID: 24061696
[TBL] [Abstract][Full Text] [Related]
10. Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation.
Merrick GS; Galbreath RW; Bennett A; Butler WM; Amamovich E
World J Urol; 2017 Jul; 35(7):1009-1013. PubMed ID: 27900453
[TBL] [Abstract][Full Text] [Related]
11. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
[TBL] [Abstract][Full Text] [Related]
12. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
13. The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies.
Pal RP; Elmussareh M; Chanawani M; Khan MA
BJU Int; 2012 Feb; 109(3):367-71. PubMed ID: 21883818
[TBL] [Abstract][Full Text] [Related]
14. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
[TBL] [Abstract][Full Text] [Related]
15. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies.
Javed S; Chadwick E; Edwards AA; Beveridge S; Laing R; Bott S; Eden C; Langley S
BJU Int; 2014 Oct; 114(4):541-8. PubMed ID: 24224648
[TBL] [Abstract][Full Text] [Related]
16. Utility of Histoscanning™ prior to prostate biopsy for the diagnosis of prostate adenocarcinoma.
Núñez-Mora C; García-Mediero JM; Patiño P; Orellana C; Garrido A; Rojo A; Rendón D
Actas Urol Esp; 2013 Jun; 37(6):342-6. PubMed ID: 23507291
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Prostate HistoScanning as a Method for Targeted Biopsy in Routine Practice.
Glybochko PV; Alyaev YG; Amosov AV; Krupinov GE; Nir D; Winkler M; Ganzha TM
Eur Urol Focus; 2019 Mar; 5(2):179-185. PubMed ID: 28753891
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
19. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
[TBL] [Abstract][Full Text] [Related]
20. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G
World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
